Announced
Financials
Tags
generic drugmaker
drug manufacturing
Egypt
Pharmaceuticals
Private
Acquisition
Pending
Majority
Single Bidder
Private Equity
Friendly
Cross Border
Synopsis
Private equity firms Development Partners International, CDC Partners and European Bank for Reconstruction and Development, agreed to acquire Adwia Pharmaceuticals, a generic drug manufacturer, from Taher family, for $250m. "We are thrilled to have brought together the consortium of DPI, CDC and EBRD, with the leadership of Hocine, Alhadi and their team, to achieve that vision. By creating this unique platform, we will deliver substantial, tangible impact by increasing the availability and affordability of quality drugs and by developing local production and reducing reliance on imported drugs across Africa," Sofiane Lahmar, DPI Partner.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.